Lexaria Bioscience Corp (LEXXW) — Strategic Asset Allocation Index
Lexaria Bioscience Corp (LEXXW) has a Strategic Asset Allocation Index of 29.2% as of November 2020. Strategic assets (PP&E of $532.51K plus long-term investments of $-) total $532.51K, measured against net assets of $1.82 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Lexaria Bioscience Corp to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Lexaria Bioscience Corp Strategic Asset Allocation Index (2016–2020)
This chart shows how Lexaria Bioscience Corp's Strategic Asset Allocation Index has evolved across 5 annual periods from 2016 to 2020. As of November 2020, the index stands at 29.2%, representing strategic assets of $532.51K against net assets of $1.82 Million USD. For live market cap and overall valuation, see Lexaria Bioscience Corp market cap and net worth.
Annual Strategic Asset Allocation Index for Lexaria Bioscience Corp (2016–2020)
The table below presents the year-by-year Strategic Asset Allocation Index for Lexaria Bioscience Corp from 2016 to 2020, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Lexaria Bioscience Corp (LEXXW) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 24.6% | $610.28K | $610.28K | $- | $2.48 Million | ▲ +0.8 pp |
| 2019 | 23.7% | $591.26K | $591.26K | $- | $2.49 Million | ▲ +23.7 pp |
| 2018 | 0.1% | $1.24K | $1.24K | $- | $2.39 Million | ▼ 0.0 pp |
| 2017 | 0.1% | $1.86K | $1.86K | $- | $2.77 Million | ▼ -2.8 pp |
| 2016 | 2.8% | $2.48K | $2.48K | $- | $87.76K | — |